232 related articles for article (PubMed ID: 28344891)
1. Tumor-infiltrating CD39
Hu G; Wu P; Cheng P; Zhang Z; Wang Z; Yu X; Shao X; Wu D; Ye J; Zhang T; Wang X; Qiu F; Yan J; Huang J
Oncoimmunology; 2017; 6(2):e1277305. PubMed ID: 28344891
[TBL] [Abstract][Full Text] [Related]
2. An IL6-Adenosine Positive Feedback Loop between CD73
Hu G; Cheng P; Pan J; Wang S; Ding Q; Jiang Z; Cheng L; Shao X; Huang L; Huang J
Cancer Immunol Res; 2020 Oct; 8(10):1273-1286. PubMed ID: 32847938
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral FoxP3
Syed Khaja AS; Toor SM; El Salhat H; Ali BR; Elkord E
Front Immunol; 2017; 8():619. PubMed ID: 28603527
[TBL] [Abstract][Full Text] [Related]
4. CD39
Ahlmanner F; Sundström P; Akeus P; Eklöf J; Börjesson L; Gustavsson B; Lindskog EB; Raghavan S; Quiding-Järbrink M
Oncotarget; 2018 Dec; 9(97):36993-37007. PubMed ID: 30651930
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
6. Regulatory γδ T cells induced by G-CSF participate in acute graft-versus-host disease regulation in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation.
Xuan L; Wu X; Qiu D; Gao L; Liu H; Fan Z; Huang F; Jin Z; Sun J; Li Y; Liu Q
J Transl Med; 2018 May; 16(1):144. PubMed ID: 29801459
[TBL] [Abstract][Full Text] [Related]
7. CD39+ regulatory T cells attenuate allergic airway inflammation.
Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
[TBL] [Abstract][Full Text] [Related]
8. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
Front Immunol; 2019; 10():2936. PubMed ID: 31921188
[TBL] [Abstract][Full Text] [Related]
9. CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer.
Li J; Wang L; Chen X; Li L; Li Y; Ping Y; Huang L; Yue D; Zhang Z; Wang F; Li F; Yang L; Huang J; Yang S; Li H; Zhao X; Dong W; Yan Y; Zhao S; Huang B; Zhang B; Zhang Y
Oncoimmunology; 2017; 6(6):e1320011. PubMed ID: 28680754
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin together with TGF-β1, IL-2 and IL-15 induces the generation of functional regulatory γδT cells from human peripheral blood mononuclear cells.
Gu Y; Hu Y; Hu K; Liao W; Zheng F; Yu X; Huang H
J Immunol Methods; 2014 Jan; 402(1-2):82-7. PubMed ID: 24275339
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer.
Timperi E; Pacella I; Schinzari V; Focaccetti C; Sacco L; Farelli F; Caronna R; Del Bene G; Longo F; Ciardi A; Morelli S; Vestri AR; Chirletti P; Barnaba V; Piconese S
Oncoimmunology; 2016 Jul; 5(7):e1175800. PubMed ID: 27622025
[TBL] [Abstract][Full Text] [Related]
12. CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8
Canale FP; Ramello MC; Núñez N; Araujo Furlan CL; Bossio SN; Gorosito Serrán M; Tosello Boari J; Del Castillo A; Ledesma M; Sedlik C; Piaggio E; Gruppi A; Acosta Rodríguez EA; Montes CL
Cancer Res; 2018 Jan; 78(1):115-128. PubMed ID: 29066514
[TBL] [Abstract][Full Text] [Related]
13. The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27.
d'Almeida SM; Kauffenstein G; Roy C; Basset L; Papargyris L; Henrion D; Catros V; Ifrah N; Descamps P; Croue A; Jeannin P; Grégoire M; Delneste Y; Tabiasco J
Oncoimmunology; 2016 Jul; 5(7):e1178025. PubMed ID: 27622030
[TBL] [Abstract][Full Text] [Related]
14. PLA2G4A promotes right-sided colorectal cancer progression by inducing CD39+γδ Treg polarization.
Zhan Y; Zheng L; Liu J; Hu D; Wang J; Liu K; Guo J; Zhang T; Kong D
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34283812
[TBL] [Abstract][Full Text] [Related]
15. IL-27 confers a protumorigenic activity of regulatory T cells via CD39.
Park YJ; Ryu H; Choi G; Kim BS; Hwang ES; Kim HS; Chung Y
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3106-3111. PubMed ID: 30718407
[TBL] [Abstract][Full Text] [Related]
16. SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.
Warren MC; Matissek S; Rausch M; Panduro M; Hall RJ; Dulak A; Brennan D; Das Yekkirala S; Koseoglu S; Masia R; Yang Y; Reddy N; Prenovitz R; Strand J; Zaidi T; Devereaux E; Foissac CJ; Stagg J; Lee BH; Holland P; Palombella VJ; Lake AC
Immunohorizons; 2023 May; 7(5):366-379. PubMed ID: 37219538
[TBL] [Abstract][Full Text] [Related]
17. Human CD39
Magid-Bernstein JR; Rohowsky-Kochan CM
J Interferon Cytokine Res; 2017 Apr; 37(4):153-164. PubMed ID: 28387597
[TBL] [Abstract][Full Text] [Related]
18. ILT4 in Colorectal Cancer Cells Induces Suppressive T Cell Contexture and Disease Progression.
Yang Z; Gao A; Shi W; Wang J; Zhang X; Xu Z; Xu T; Zheng Y; Sun Y; Yang F
Onco Targets Ther; 2021; 14():4239-4254. PubMed ID: 34321889
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
[TBL] [Abstract][Full Text] [Related]
20. CD39
Feng Y; Xu X; Zhang J; Sanderson C; Xia J; Bu Z; Yang Y; Yang P; Lu Z
Am J Cancer Res; 2024; 14(2):585-600. PubMed ID: 38455401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]